Yin et al. developed estrone-modified glycol chitosan nanoparticles (GCNP-ES) for breast cancer treatment because estrogen receptor (ER) is overexpressed in breast cancer tissues compared to normal mammary glands [65]. The gene discussed is ESR1; the disease is breast cancer.